Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPIRAL: Atorvastatin for ICI-induced Atherosclerosis
NCT06785974Phase 4Not yet recruiting
- Sponsor
- Erasmus MC
- Start
- Feb 2025
- Primary completion
- Feb 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of atorvastatin in atherosclerosis, sponsored by Erasmus MC. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
atorvastatin
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT06785974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06785974.